Submissions Deadline: August 31, 2024 Selection: The main selection criterion will be the highest score on an abstract submitted for the CUGH annual meeting Dr
Until more data is available, use in patients with recent heart attacks or severe heart failure should be approached cautiously under medical supervision
DPP-4i also has reno-protective effects independent of glycemic control
Oral mucosal melanin hyperpigmentation associated with syndromes and systemic diseases Oral mucosal melanin hyperpigmentation is often observed in the systemic conditions such as Peutz-Jegher syndrome, McCune-Albright syndrome, Laugier-Hunziker syndrome, Addison disease, and neurofibromatosis
Les arrived and was amazing, got me set up with the right treatment
As of February 2026, Lilly plans to submit for orforglipron for type 2 diabetes sometime in 2026